Role of microRNAs in maintaining cancer stem cells

Advanced Drug Delivery Reviews

Volumn 81, Issue , 2015, Pages 53-61

  Garofalo, Michela ^a,b   Croce, Carlo M ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Cancer; Cancer stem cells; Embryonic stem cells (ESCs); EMT; MicroRNAs

Indexed keywords

CELLS; CYTOLOGY; DISEASES; DRUG THERAPY; RNA; TUMORS;

CANCER; CANCER STEM CELLS; EMBRYONIC STEM CELLS; EMT; MICRORNAS;

STEM CELLS;

MICRORNA; ANTINEOPLASTIC AGENT;

BIOGENESIS; BRAIN TUMOR; BREAST CANCER; CANCER STEM CELL; COLON CANCER; EMBRYONIC STEM CELL; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; LEUKEMIA; LIVER CANCER; LUNG CANCER; MOLECULAR PATHOLOGY; NONHUMAN; PROSTATE CANCER; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; DRUG RESISTANCE; GENETICS; METABOLISM; METASTASIS; NEOPLASM; PATHOLOGY;

ANIMALS; ANTINEOPLASTIC AGENTS; DRUG RESISTANCE, NEOPLASM; HUMANS; MICRORNAS; NEOPLASM METASTASIS; NEOPLASMS; NEOPLASTIC STEM CELLS;

EID: 84922219556     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2014.11.014     Document Type: Review

References (104)

1. Vogelstein B., Fearon E.R., Hamilton S.R., Kern S.E., Preisinger A.C., Leppert M., Nakamura Y., White R., Smits A.M., Bos J.L. Genetic alterations during colorectal-tumor development. N. Engl. J. Med. 1988, 319:525-532.
2. Passegué E., Jamieson C.H., Ailles L.E., Weissman I.L. Normal and leukemic hematopoiesis: are leukemias a stem cell disorder or a reacquisition of stem cell characteristics?. Proc. Natl. Acad. Sci. U. S. A. 2003, 100(Suppl. 1):11842-11849.
3. Sell S. Stem cell origin of cancer and differentiation therapy. Crit. Rev. Oncol. Hematol. 2004, 51:1-28.
4. Durante F. Nesso fisio-pathologico tra la struttura dei nei materni e la genesi di alcuni tumori maligni. Arch. Mem. Obs. Chir. Pract. 1874, 11:217-226.
5. Cohnheim J. Ueber entzundung und eiterung. Path. Anat. Physiol. Klin. Med. 1867, 40:1-79.
6. Cohnheim J. Congenitales, quergestreiftes Muskelsarkonder Nireren. Virchows Arch. 1875, 65:64.
7. Jordan C.T. Unique molecular and cellular features of acute myelogenous leukemia stem cells. Leukemia 2002, 16:559-562.
8. Spangrude G.J., Heimfeld S., Weissman I.L. Purification and characterization of mouse hematopoietic stem cells. Science 1988, 241:58-62.
9. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:3983-3988.
10. Ignatova T.N., Kukekov V.G., Laywell E.D., Suslov O.N., Vrionis F.D., Steindler D.A. Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro. Glia 2002, 193:193-206.
11. Singh S.K., Clarke I.D., Terasaki M., Bonn V.E., Hawkins C., Squire J., et al. Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003, 63:5821-5828.
12. Driessens G., Beck B., Caauwe A., Simons B.D., Blanpain C. Defining the mode of tumour growth by clonal analysis. Nature 2012, 488:527-530.
13. Schepers A.G., Snippert H.J., Stange D.E., van den Born M., van Es J.H., van de Wetering M., et al. Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas. Science 2012, 337:730-735.
14. Chen J., Li Y., Yu T.S., McKay R.M., Burns D.K., Kernie S.G., et al. A restricted cell population propagates glioblastoma growth after chemotherapy. Nature 2012, 488:522-526.
15. Gregory R.I., Yan K.P., Amuthan G., Chendrimada T., Doratotaj B., Cooch N., Shiekhattar R. The Microprocessor complex mediates the genesis of microRNAs. Nature 2004, 432:235-240.
16. Bohnsack M.T., Czaplinski K., Gorlich D. Exportin 5 is a RanGTP-dependent dsRNA-binding protein that mediates nuclear export of pre-miRNAs. RNA 2004, 10:185-191.
17. Kim V.N., Han J., Siomi M.C. Biogenesis of small RNAs in animals. Nat. Rev. Mol. Cell Biol. 2009, 10:126-139.
18. Smith A.G. Embryo-derived stem cells: of mice and men. Annu. Rev. Cell Dev. Biol. 2001, 17:435-462.
19. Lee R.C., Feinbaum R.L., Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75:843-854.
20. Reinhart B.J., Slack F.J., Basson M., Pasquinelli A.E., Bettinger J.C., Rougvie A.E., et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 2000, 403:901-906.
21. Pasquinelli A.E., Reinhart B.J., Slack F., Martindale M.Q., Kuroda M.I., Maller B., D.C., et al. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 2000, 408:86-89.
22. Bernstein E., Kim S.Y., Carmell M.A., Murchison E.P., Alcorn H., Li M.Z., et al. Dicer is essential for mouse development. Nat. Genet. 2003, 35:215-217.
23. Boyer L.A., Lee T.I., Cole M.F., Johnstone S.E., Levine S.S., Zucker J.P., et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 2005, 122:947-956.
24. Loh Y.H., Wu Q., Chew J.L., Vega V.B., Zhang W., Chen X., G., et al. The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat. Genet. 2006, 38:431-440.
25. Wang S., Tang X., Niu Y., Chen H., Li B., Li T., et al. Generation and characterization of rabbit embryonic stem cells. Stem Cells 2007, 25:481-489.
26. Sinkkonen L., Hugenschmidt T., Berninger P., Gaidatzis D., Mohn F., Artus-Revel C.G., et al. MicroRNAs control de novo DNA methylation through regulation of transcriptional repressors in mouse embryonic stem cells. Nat. Struct. Mol. Biol. 2008, 15:259-267.
27. Card D.A., Hebbar P.B., Li L., Trotter K.W., Komatsu Y., Mishina Y., et al. Oct4/Sox2-regulated miR-302 targets cyclin D1 in human embryonic stem cells. Mol. Cell. Biol. 2008, 28:6426-6438.
28. Melton C., Judson R.L., Blelloch R. Opposing microRNA families regulate self-renewal in mouse embryonic stem cells. Nature 2010, 463:621-626.
29. Choi Y.J., Lin C.P., Ho J.J., He X., Okada N., et al. miR-34 miRNAs provide a barrier for somatic cell reprogramming. Nat. Cell Biol. 2011, 13:1353-1360.
30. Aranha M.M., Santos D.M., Solá S., Steer C.J., Rodrigues C.M. miR-34a regulates mouse neural stem cell differentiation. PLoS One 2011, 6:e21396.
31. Zhao X., Yang Z., Li G., Li D., Zhao Y., Wu Y., et al. The role and clinical implications of microRNAs in hepatocellular carcinoma. Sci. China Life Sci. 2012, 55:906-919.
32. Po A., Ferretti E., Miele E., De Smaele E., Paganelli A., Canettieri G. Hedgehog controls neural stem cells through p53-independent regulation of Nanog. EMBO J. 2010, 29:2646-2658.
33. Rodova M., Fu J., Watkins D.N., Srivastava R.K., Shankar S. Sonic hedgehog signaling inhibition provides opportunities for targeted therapy by sulforaphane in regulating pancreatic cancer stem cell self-renewal. PLoS One 2012, 7:e46083.
34. Cheng Y., Cheung A.K., Ko J.M., Phoon Y.P., Chiu P.M., Lo P.H. Physiological β-catenin signaling controls self-renewal networks and generation of stem-like cells from nasopharyngeal carcinoma. BMC Cell Biol. 2013, 14:44.
35. van den Berg D.L., Snoek T., Mullin N.P., Yates A., Bezstarosti K., Demmers J. An Oct4-centered protein interaction network in embryonic stem cells. Cell Stem Cell 2010, 6:369-381.
36. Ji J., Yamashita T., Budhu A., Forgues M., Jia H.L., Li C., et al. Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells. Hepatology 2009, 50:472-480.
37. Suetsugu A., Nagaki M., Aoki H., Motohashi T., Kunisada T., Moriwaki H. Characterization of CD133+ hepatocellular carcinoma cells as cancer stem/progenitor cells. Biochem. Biophys. Res. Commun. 2006, 351:820-824.
38. Yin S., Li J., Hu C., Chen X., Yao M., Yan M., et al. CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity. Int. J. Cancer 2007, 120:1444-1450.
39. Zhang J., Luo N., Luo Y., Peng Z., T., Li S. microRNA-150 inhibits human CD133-positive liver cancer stem cells through negative regulation of the transcription factor c-Myb. Int. J. Oncol. 2012, 40:747-756.
40. Ma S., Tang K.H., Chan Y.P., Lee T.K., Kwan P.S., Castilho A., et al. Cell Stem Cell 2010, 7:694-707.
41. Liu A.M., Yao T.J., Wang W., Wong K.F., Lee N.P., Fan S.T., et al. Circulating miR-15b and miR-130b in serum as potential markers for detecting hepatocellular carcinoma: a retrospective cohort study. BMJ Open 2012, 2:e000825.
42. Jia Y., Liu H., Zhuang Q., Xu S., Yang Z., Li J., et al. Tumorigenicity of cancer stem-like cells derived from hepatocarcinoma is regulated by microRNA-145. Oncol. Rep. 2012, 27:1865-1872.
43. Han Y.C., Park C.Y., Bhagat G., Zhang J., Wang Y., Fan J.B., et al. microRNA-29a induces aberrant self-renewal capacity In hematopoietic progenitors, biased myeloid development, and acute myeloid leukemia. J. Exp. Med. 2010, 207:475-489.
44. T. Lapidot, C. Sirard, J. Vormoor, B. Murdoch, T. Hoang, J. Caceres-Cortes, M. Minden, B. Paterson, M.A. Caligiuri and J.E. Dick: A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature, 367 645-8.
45. de Leeuw D.C., Denkers F., Olthof M., Rutten A., Pouwels W., et al. Attenuation of microRNA-126 expression that drives CD34+38- stem/progenitor cells in acute myeloid leukemia leads to tumor eradication. Cancer Res. 2014, 74:2094-2105.
46. Arnold C.P., Tan R., Zhou B., Yue S.B., Schaffert S., Biggs J.R., Doyonnas R., et al. MicroRNA programs in normal and aberrant stem and progenitor cells. Genome Res. 2011, 21:798-810.
47. Song S.J., Ito K., Ala U., Kats L., Webster K., Sun S.M., et al. The oncogenic microRNA miR-22 targets the TET2 tumor suppressor to promote hematopoietic stem cell self-renewal and transformation. Cell Stem Cell 2013, 13:87-101.
48. Morris V.A., Zhang A., Yang T., Stirewalt D.L., Ramamurthy R., Meshinchi S., et al. MicroRNA-150 expression induces myeloid differentiation of human acute leukemia cells and normal hematopoietic progenitors. PLoS One 2013, 8:e75815.
49. Babashah S., Sadeghizadeh M., Hajifathali A., Tavirani M.R., Zomorod M.S., Ghadiani M., et al. Targeting of the signal transducer Smo links microRNA-326 to the oncogenic Hedgehog pathway in CD34+ CML stem/progenitor cells. Int. J. Cancer 2013, 133:579-589.
50. Schwarzenbacher D., Balic M., Pichler M. The role of microRNAs in breast cancer stem cells. Int. J. Mol. Sci. 2013, 14:14712-14723.
51. Ginestier C., Hur M.H., Charafe-Jauffret E., Monville F., Dutcher J., Brown M., et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007, 1:555-567.
52. Iliopoulos D., Hirsch H.A., Struhl K. An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation. Cell 2009, 139:693-706.
53. Lim Y.Y., Wright J.A., Attema J.L., Gregory P.A., Bert A.G., Smith E., et al. Epigenetic modulation of the miR-200 family is associated with transition to a breast cancer stem-cell-like state. J. Cell Sci. 2013, 126:2256-2266.
54. Sun X., Qin S., Fan C., Xu C., Du N., Ren H. Let-7: a regulator of the ERα signaling pathway in human breast tumors and breast cancer stem cells. Oncol. Rep. 2013, 29:2079-2087.
55. Okuda H., Xing F., Pandey P.R., Sharma S., Watabe M., Pai S.K., et al. miR-7 suppresses brain metastasis of breast cancer stem-like cells by modulating KLF4. Cancer Res. 2013, 73:1434-1444.
56. Yu F., Deng H., Yao H., Liu Q., Su F., Song E. Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells. Oncogene 2010, 29:4194-4204.
57. Zhu Y., Yu F., Jiao Y., Feng J., Tang W., Yao H., Gong C., et al. Reduced miR-128 in breast tumor-initiating cells induces chemotherapeutic resistance via Bmi-1 and ABCC5. Clin. Cancer Res. 2011, 17:7105-7115.
58. Liu L., Zhou W., Cheng C.T., Ren X., Somlo G., Fong M.Y. TGFbeta Induces 'BRCAness' and Sensitivity to PARP Inhibition in Breast Cancer by Regulating DNA Repair Genes. Mol. Cancer Res. 2014, 12:1597-1609.
59. Li Q., Yao Y., Eades G., Liu Z., Zhang Y., Zhou Q. Downregulation of miR-140 promotes cancer stem cell formation in basal-like early stage breast cancer. Oncogene 2014, 33:2589-2600.
60. Fang Y., Xiang J., Chen Z., Gu X., Li Z., Tang F., et al. miRNA expression profile of colon cancer stem cells compared to non-stem cells using the SW1116 cell line. Oncol. Rep. 2012, 28:2115-2124.
61. Bitarte N., Bandres E., Boni V., Zarate R., Rodriguez J., Gonzalez-Huarriz M., et al. MicroRNA-451 is involved in the self-renewal, tumorigenicity, and chemoresistance of colorectal cancer stem cells. Stem Cells 2011, 29:1661-1671.
62. Pinto D., Gregorieff A., Begthel H., Clevers H. Canonical Wnt signals are essential for homeostasis of the intestinal epithelium. Genes Dev. 2003, 17:1709-1713.
63. Vermeulen L., De Sousa E.M.F., van der Heijden M., Cameron K., de Jong J.H., Borovski T., et al. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat. Cell Biol. 2010, 12:468-476.
64. Yu Y., Kanwar S.S., Patel B.B., Oh P.S., Nautiyal J., Sarkar F.H., Majumdar A.P. MicroRNA-21 induces stemness by downregulating transforming growth factor beta receptor 2 (TGFbetaR2) in colon cancer cells. Carcinogenesis 2012, 33:68-76.
65. Fre S., Huyghe M., Mourikis P., Robine S., Louvard D., Artavanis-Tsakonas S. Notch signals control the fate of immature progenitor cells in the intestine. Nature 2005, 435:964-968.
66. Bu P., Chen K.Y., Chen J.H., Wang L., Walters J., Shin Y.J., et al. A microRNA miR-34a-regulated bimodal switch targets Notch in colon cancer stem cells. Cell Stem Cell 2013, 12:602-615.
67. Ho M.M., Ng A.V., Lam S., Hung Y.J. Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res. 2007, 67:4827-4833.
68. Levina V., Marrangoni A.M., DeMarco R., Gorelik E., Lokshin A.E. Drug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties. PLoS One 2008, 3:e3077.
69. Jiang F., Qiu Q., Khanna A., Todd N.-W., Deepak J., Xing L., et al. Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer. Mol. Cancer Res. 2009, 7:330-338.
70. Eramo A., Lotti F., Sette G., Pilozzi E., Biffoni M., Di Virgilio A., et al. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ. 2008, 15:504-514.
71. Leung E.L., Fiscus R.R., Tung J.W., Tin V.P., Cheng L.C., Sihoe A.D., et al. Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties. PLoS One 2010, 5:e14062.
72. Qiu X., Wang Z., Li Y., Miao Y., Ren Y., Luan Y. Characterization of sphere-forming cells with stem-like properties from the small cell lung cancer cell line H446. Cancer Lett. 2012, 323:161-170.
73. Marhaba R., Zoller M. CD44 in cancer progression: adhesion, migration and growth regulation. J. Mol. Histol. 2004, 35:211-231.
74. Desai T.J., Brownfield D.G., Krasnow M.A. Alveolar progenitor and stem cells in lung development, renewal and cancer. Nature 2014, 507:190-194.
75. Shi Y., Liu C., Liu X., Tang D.G., Wang J. The microRNA miR-34a inhibits non-small cell lung cancer (NSCLC) growth and the CD44hi stem-like NSCLC cells. PLoS One 2014, 9:e90022.
76. Gutova M., Najbauer J., Gevorgyan A., Metz M.Z., Weng Y., Shih C.C. Identification of uPAR-positive chemoresistant cells in small cell lung cancer. PLoS One 2007, 2:e243.
77. Miao Y., Li J., Qiu X., Li Y., Wang Z., Luan Y. miR-27a regulates the self-renewal of the H446 small cell lung cancer cell line in vitro. Oncol. Rep. 2013, 29:161-168.
78. Vaz A.P., Ponnusamy M.P., Batra S.K. Cancer stem cells and therapeutic targets: an emerging field for cancer treatment. Drug Deliv. Transl. Res. 2013, 3:113-120.
79. Xu W., Ji J., Xu Y., Liu Y., Shi L., Liu Y. MicroRNA-191, by promoting the EMT and increasing CSC-like properties, is involved in neoplastic and metastatic properties of transformed human bronchial epithelial cells. Mol. Carcinog. 2014, (Epub ahead of print).
80. Jiang Z., Cushing L., Ai X., Lü J. miR-326 is downstream of sonic hedgehog signaling and regulates the expression of Gli2 and smoothened. Am. J. Respir. Cell Mol. Biol. 2014, 51:273-283.
81. Tu Y., Gao X., Li G., Fu H., Cui D., Liu H., et al. MicroRNA-218 inhibits glioma invasion, migration, proliferation, and cancer stem-like cell self-renewal by targeting the polycomb group gene Bmi1. Cancer Res. 2013, 73:6046-6055.
82. Chen L., Chen X.R., Chen F.F., Liu Y., Li P., Zhang R., et al. MicroRNA-107 inhibits U87 glioma stem cells growth and invasion. Cell. Mol. Neurobiol. 2013, 33:651-657.
83. Peruzzi P., Bronisz A., Nowicki M.O., Wang Y., Ogawa D., Price R., et al. miR-128 coordinately targets polycomb repressor complexes in glioma stem cells. Neuro Oncol. 2013, 15:1212-1224.
84. Niu C.S., Yang Y., Cheng C.D. MiR-134 regulates the proliferation and invasion of glioblastoma cells by reducing Nanog expression. Int. J. Oncol. 2013, 42:1533-1540.
85. Zhao S., Deng Y., Liu Y., Chen X., Yang G., Mu Y., et al. MicroRNA-153 is tumor suppressive in glioblastoma stem cells. Mol. Biol. Rep. 2013, 40:2789-2798.
86. Ying Z., Li Y., Wu J., Zhu X., Yang Y., Tian H., et al. Loss of miR-204 expression enhances glioma migration and stem cell-like phenotype. Cancer Res. 2013, 73:990-999.
87. Liu C., Kelnar K., Liu B., Chen X., Calhoun-Davis T., Li H., et al. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat. Med. 2011, 17:211-215.
88. Ren D., Wang M., Guo W., Zhao X., Tu X., Huang S., et al. Wild-type p53 suppresses the epithelial-mesenchymal transition and stemness in PC-3 prostate cancer cells by modulating miR-145. Int. J. Oncol. 2013, 42:1473-1481.
89. Tay Y.M., Tam W.L., Ang Y.S., Gaughwin P.M., Yang H., Wang W., et al. MicroRNA-134 modulates the differentiation of mouse embryonic stem cells, where it causes post-transcriptional attenuation of Nanog and LRH1. Stem Cells 2008, 26:17-29.
90. Ngalame N.N., Tokar E.J., Person R.J., Xu Y., Waalkes M.P. Aberrant microRNA Expression Likely Controls RAS Oncogene Activation During Malignant Transformation of Human Prostate Epithelial and Stem Cells by Arsenic. Toxicol. Sci. 2014, 138:268-277.
91. Iliopoulos D., Hirsch H.A., Wang G., Struhl K. Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:1397-1402.
92. Saini S., Majid S., Shahryari V., Arora S., Yamamura S., Chang I. miRNA-708 control of CD44(+) prostate cancer-initiating cells. Cancer Res. 2012, 72:3618-3630.
93. Mani S.A., Guo W., Liao M.J., Eaton E.N., Ayyanan A., Zhou A.Y. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008, 133:704-715.
94. Chaffer C.L., Marjanovic N.D., Lee T., Bell G., Kleer C.G., Reinhardt F. Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity. Cell 2013, 154:61-74.
95. Park S.M., Gaur A.B., Lengyel E., Peter M.E. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev. 2008, 22:894-907.
96. Qian P., Banerjee A., Wu Z.S., Zhang X., Wang H., Pandey V. Loss of SNAIL regulated miR-128-2 on chromosome 3p22.3 targets multiple stem cell factors to promote transformation of mammary epithelial cells. Cancer Res. 2012, 72:6036-6050.
97. Liu Y., Sánchez-Tilló E., Lu X., Huang L., Clem B., Telang S. The ZEB1 transcription factor acts in a negative feedback loop with miR200 downstream of Ras and Rb1 to regulate Bmi1 expression. J. Biol. Chem. 2014, 14:4116-4125.
98. Siemens H., Jackstadt R., Hünten S., Kaller M., Menssen A., Götz U., et al. miR-34 and SNAIL form a double-negative feedback loop to regulate epithelial-mesenchymal transitions. Cell Cycle 2011, 10:4256-4271.
99. Liu Z., Liu H., Desai S., Schmitt D.C., Zhou M., Khong H.T. miR-125b functions as a key mediator for snail-induced stem cell propagation and chemoresistance. J. Biol. Chem. 2013, 288:4334-4345.
100. Yin G., Chen R., Alvero A.B., Fu H.H., Holmberg J., Glackin C. TWISTing stemness, inflammation and proliferation of epithelial ovarian cancer cells through MIR199A2/214. Oncogene 2010, 29:3545-3553.
101. Nanta R., Kumar D., Meeker D., Rodova M., Van Veldhuizen P.J., Shankar S. NVP-LDE-225 (Erismodegib) inhibits epithelial-mesenchymal transition and human prostate cancer stem cell growth in NOD/SCID IL2Rγ null mice by regulating Bmi-1 and microRNA-128. Oncogenesis 2013, 2:e42.
102. Gill J.G., Langer E.M., Lindsley R.C., Cai M., Murphy T.L., Murphy K.M. Snail promotes the cell-autonomous generation of Flk1(+) endothelial cells through the repression of the microRNA-200 family. Stem Cells Dev. 2012, 21:167-176.
103. Polytarchou C., Iliopoulos D., Struhl K. An integrated transcriptional regulatory circuit that reinforces the breast cancer stem cell state. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:14470-14475.
104. Karsten U., Goletz S. What makes cancer stem cell markers different?. Springerplus 2013, 2:301.